The Global Antimicrobial Suture Market size is expected to reach $367.5 million by 2031, rising at a market growth of 3.5% CAGR during the forecast period.
North America, especially the United States and Canada, has some of the most advanced healthcare systems in the world. The emphasis on high standards of care drives the adoption of advanced medical products, including antimicrobial sutures, to ensure the best outcomes for patients. The region strongly focuses on infection control measures in hospitals and outpatient settings. Antimicrobial sutures meet these stringent infection control standards and prevent complications from surgical site infections. Thus, the North America 37% region acquired revenue share in the market 2023.
Hospitals and surgical centers are increasingly adopting stringent infection control protocols to improve patient safety and minimize the risk of postoperative infections. Antimicrobial sutures play a crucial role in these protocols by reducing the incidence of infections at the surgical site.
Additionally, as healthcare expenditure rises, there is greater investment in advanced medical technologies and products, including antimicrobial sutures. Healthcare facilities with increased budgets can afford to incorporate the latest innovations, such as antimicrobial sutures, to improve patient care and infection control.
However, many healthcare facilities, especially those with limited budgets, may struggle to justify the higher cost of antimicrobial sutures compared to traditional sutures. Budget constraints can limit the ability of these facilities to invest in advanced technologies, potentially leading to a preference for more cost-effective alternatives. Thus, the high cost of antimicrobial sutures hampers the market's growth.
The pandemic caused interruptions in clinical trials and research for new antimicrobial sutures. Delays in research and development affected the progress of innovative products and solutions. With a shift in focus towards COVID-19-related research, developing and testing antimicrobial sutures faced delays. This shift impacted on the introduction of new and improved products in the market. Thus, the COVID-19 pandemic had a negative impact on the market.
North America, especially the United States and Canada, has some of the most advanced healthcare systems in the world. The emphasis on high standards of care drives the adoption of advanced medical products, including antimicrobial sutures, to ensure the best outcomes for patients. The region strongly focuses on infection control measures in hospitals and outpatient settings. Antimicrobial sutures meet these stringent infection control standards and prevent complications from surgical site infections. Thus, the North America 37% region acquired revenue share in the market 2023.
Hospitals and surgical centers are increasingly adopting stringent infection control protocols to improve patient safety and minimize the risk of postoperative infections. Antimicrobial sutures play a crucial role in these protocols by reducing the incidence of infections at the surgical site.
Additionally, as healthcare expenditure rises, there is greater investment in advanced medical technologies and products, including antimicrobial sutures. Healthcare facilities with increased budgets can afford to incorporate the latest innovations, such as antimicrobial sutures, to improve patient care and infection control.
However, many healthcare facilities, especially those with limited budgets, may struggle to justify the higher cost of antimicrobial sutures compared to traditional sutures. Budget constraints can limit the ability of these facilities to invest in advanced technologies, potentially leading to a preference for more cost-effective alternatives. Thus, the high cost of antimicrobial sutures hampers the market's growth.
The pandemic caused interruptions in clinical trials and research for new antimicrobial sutures. Delays in research and development affected the progress of innovative products and solutions. With a shift in focus towards COVID-19-related research, developing and testing antimicrobial sutures faced delays. This shift impacted on the introduction of new and improved products in the market. Thus, the COVID-19 pandemic had a negative impact on the market.
Driving and Restraining Factors
Drivers
- Growing focus on infection control protocols
- Increasing healthcare expenditure worldwide
- Rising incidence of surgical site infections (SSIs)
Restraints
- High cost of antimicrobial sutures
- Increasing competition from alternative technologies
Opportunities
- Rising demand for minimally invasive surgeries
- Growth in sports medicine
Challenges
- Potential for antimicrobial resistance
- High replacement rate of antimicrobial sutures
End Use Outlook
On the basis of end user, the market is segmented into hospitals, clinics, and others. The hospitals segment recorded 68% revenue share in the market in 2023. Hospitals perform many surgeries daily across various specialties, including general surgery, orthopedics, cardiology, and gynecology.Type Outlook
Based on type, the market is divided into absorbable and non-absorbable. The non-absorbable segment procured 33% revenue share in the market in 2023. Non-absorbable sutures provide long-term support for tissues that require prolonged stabilization, making them ideal for high-tension areas or where long-term durability is essential.Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 26% revenue share in the market. With the growth of healthcare facilities and advancements in medical technology, there has been an increase in the number of surgical procedures performed in the Asia-Pacific region.List of Key Companies Profiled
- Conmed Corporation
- Smith & Nephew plc
- Demetech Corporation
- Medtronic PLC
- Braun Melsungen AG
- W.L. Gore & Associates, Inc.
- Boston Scientific Corporation
- Johnson & Johnson
- Peters Surgical
- Stryker Corporation
Market Report Segmentation
By Type
- Absorbable
- Non absorbable
By End User
- Hospitals
- Clinics
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Antimicrobial Suture Market by Type
Chapter 5. Global Antimicrobial Suture Market by End User
Chapter 6. Global Antimicrobial Suture Market by Region
Chapter 7. Company Profiles
Companies Mentioned
- Conmed Corporation
- Smith & Nephew plc
- Demetech Corporation
- Medtronic PLC
- B. Braun Melsungen AG
- W. L. Gore & Associates, Inc.
- Boston Scientific Corporation
- Johnson & Johnson
- Peters Surgical
- Stryker Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 183 |
| Published | August 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 282.6 Million |
| Forecasted Market Value ( USD | $ 367.5 Million |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
